相关实验视频
Updated: Jun 17, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
调节胃肠道运输的药物 影响住院患者 血糖 血糖
Amanda Momenzadeh1, Caleb Cranney2, So Yung Choi3
1Department of Computational Biomedicine; Cedars-Sinai; Los Angeles, CA USA.
medRxiv : the preprint server for health sciences
|August 12, 2024
概括
许多药物,包括一些影响胃肠道运动性的药物,可以改变住院患者的血糖 (BG). 这项研究确定了10种影响BG的新药,改善了血糖管理和患者安全.
科学领域:
- 临床药理学 临床药理学
- 医疗信息学 医疗信息学
- 内分泌学 在内分泌学.
背景情况:
- 住院患者由于许多因素而表现出复杂的血糖 (BG) 变化.
- 现有的关于影响BG的药物的知识是不完整的,这可能会危及患者的安全和血糖控制.
- 识别新型药物诱导的BG变化对于改善临床实践至关重要.
研究的目的:
- 识别以前未被认可的药物,这些药物在住院患者中显著影响血糖水平.
- 分析各种因素与BG变异性之间的关系的强度和时间.
- 通过发现新的药物-BG关联来提高患者安全和血糖管理.
主要方法:
- 利用电子健康记录 (EHR) 数据从超过10万住院患者的遭遇跨越8年.
- 提取了500多种药物,实验室结果和BG的临床预测指标的数据.
- 采用拉索回归来选择特征和线性混合模型来确定统计学意义,与药物不良事件数据库进行验证.
主要成果:
- 确定了29个与BG变异性相关的统计学意义上的特征.
- 发现了10种以前未被证实会影响BG的药物,包括胃肠机动性剂.
- 其他重要的预测因素包括种族,2型糖尿病史,先前的BG水平和肌素.
结论:
- 这项研究强调了影响胃肠道过渡的药物作为BG变异性的新型预测因素.
- 研究结果表明,某些药物需要在患有或有高血糖或低血糖风险的患者中谨慎使用.
- 需要进行进一步的研究,以充分将这些发现纳入临床决策,以改善患者护理.
相关概念视频
Factors Influencing Drug Absorption: Disease States and Pharmacology
472
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
472
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
168
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
168
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
290
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
290
Drug Absorption: Factors Affecting GI Absorption
3.9K
The process of oral drug absorption can be influenced by several factors. Weakly acidic drugs tend to be absorbed more readily from the stomach due to their nonionized state. However, absorption may be less efficient in the upper intestine, where drugs are often ionized. Interestingly, despite the stomach's apparent advantage for drug absorption, its mucous layer can hinder diffusion. Its surface area is also smaller than the intestine's, which can further slow down the absorption rate.
3.9K
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
113
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
113
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
233
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
233

![Assessment of Gastric Emptying in Non-obese Diabetic Mice Using a [13C]-octanoic Acid Breath Test](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F50301.jpg&w=3840&q=50)